| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.84B | 43.49B | 41.18B | 38.26B | 32.29B | 27.99B |
| Gross Profit | 32.49B | 32.26B | 30.42B | 27.68B | 23.85B | 20.46B |
| EBITDA | 11.03B | 10.39B | 9.94B | 9.16B | 7.54B | 6.47B |
| Net Income | 6.12B | 6.41B | 6.18B | 5.71B | 4.60B | 3.56B |
Balance Sheet | ||||||
| Total Assets | 54.60B | 56.35B | 51.86B | 46.84B | 43.01B | 43.61B |
| Cash, Cash Equivalents and Short-Term Investments | 4.82B | 4.08B | 4.32B | 2.62B | 2.72B | 6.41B |
| Total Debt | 8.83B | 8.49B | 8.69B | 5.65B | 6.30B | 2.55B |
| Total Liabilities | 23.42B | 23.22B | 22.77B | 19.66B | 19.42B | 14.61B |
| Stockholders Equity | 31.18B | 33.13B | 29.07B | 27.18B | 23.59B | 28.99B |
Cash Flow | ||||||
| Free Cash Flow | 7.40B | 6.64B | 6.12B | 4.93B | 5.65B | 5.48B |
| Operating Cash Flow | 9.02B | 8.29B | 7.60B | 6.28B | 6.73B | 6.45B |
| Investing Cash Flow | -1.39B | -3.70B | -4.14B | -2.22B | -1.63B | -2.64B |
| Financing Cash Flow | -5.46B | -4.79B | -1.61B | -4.08B | -8.86B | -2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | €2.36B | 16.83 | 20.31% | 3.37% | 9.68% | 19.46% | |
75 Outperform | €6.86B | 9.85 | 18.37% | 18.51% | 1.16% | 314.94% | |
73 Outperform | €1.61B | 17.39 | 18.22% | 1.14% | 10.55% | 13.50% | |
71 Outperform | €193.82B | 31.77 | 20.13% | 1.95% | 2.60% | -5.44% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | €5.58B | 11.13 | ― | 6.25% | 7.04% | 73.35% | |
56 Neutral | €61.15M | -6.05 | ― | 3.65% | -3.97% | -269.15% |